Lianying Ge

464 total citations
22 papers, 354 citations indexed

About

Lianying Ge is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lianying Ge has authored 22 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Lianying Ge's work include Gastric Cancer Management and Outcomes (4 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA modifications and cancer (3 papers). Lianying Ge is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), Cancer, Lipids, and Metabolism (3 papers) and RNA modifications and cancer (3 papers). Lianying Ge collaborates with scholars based in China, United States and United Kingdom. Lianying Ge's co-authors include Jiaxiang Ye, Yuzhou Qin, Rong Liang, Yan Lin, Tim J. Harrison, Caroline Sabin, Zhong‐Liao Fang, Qin-Yan Chen, Xueyan Wang and Jin-ye Yang and has published in prestigious journals such as PLoS ONE, The American Journal of Gastroenterology and Journal of Cellular Biochemistry.

In The Last Decade

Lianying Ge

22 papers receiving 354 citations

Peers

Countries citing papers authored by Lianying Ge

Since Specialization

Citations

This map shows the geographic impact of Lianying Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianying Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianying Ge more than expected).

Fields of papers citing papers by Lianying Ge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianying Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianying Ge. The network helps show where Lianying Ge may publish in the future.

Co-authorship network of co-authors of Lianying Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Lianying Ge. A scholar is included among the top collaborators of Lianying Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianying Ge. Lianying Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Computed tomography radiomics signature via machine learning predicts RRM2 and overall survival in hepatocellular carcinoma 2023 ·Journal of Gastrointestinal Oncology ·Qian Li, (unknown), Yan Lin, Rong Liang, Yongqiang Li, Lianying Ge	6
2	Preoperative Neutrophil-BMI Ratio As a Promising New Marker for Predicting Tumor Outcomes in Colorectal Cancer 2022 ·Technology in Cancer Research & Treatment ·(unknown), Xiaoliang Huang, Chunyin Wei, Xianwei Mo, (unknown), Lihua Zhang, Lianying Ge, Weizhong Tang, Jungang Liu	3
3	Profiles of alternative splicing events in the diagnosis and prognosis of Gastric Cancer 2021 ·Journal of Cancer ·Chunyin Wei, (unknown), Xiaoliang Huang, (unknown), Zujun Liu, (unknown), Yongsheng Meng, (unknown), Lianying Ge, Lihua Zhang, (unknown), Jungang Liu, Weizhong Tang	2
4	Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment 2021 ·Journal of Inflammation Research ·Min Luo, Yan Lin, Rong Liang, Yongqiang Li, Lianying Ge	21
5	H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro 2021 ·Medical Science Monitor ·(unknown), (unknown), Yan Lin, Rong Liang, Yongqiang Li, Lianying Ge	15
6	Risk scoring based on expression of long non‑coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis 2020 ·Oncology Reports ·Jiaxiang Ye, (unknown), Shan Pan, Junqi Huang, Lianying Ge	25
7	Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A‐3 gene as pivotal in hepatocellular carcinoma 2020 ·Journal of Cellular Biochemistry ·Yan Lin, Rong Liang, Yingwei Mao, Jiazhou Ye, Rongyun Mai, Xing Gao, (unknown), (unknown), Qian Li, Min Luo, Lianying Ge, Yongqiang Li, Donghua Zou	13
8	Analysis of cancer incidence and mortality in Guangxi cancer registration areas, 2016 2020 ·Qiulin Li, (unknown), Minhua Rong, Lianying Ge, (unknown), (unknown)	1
9	<p>Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: a propensity score matching analysis</p> 2019 ·Cancer Management and Research ·Liucheng Wu, Lianying Ge, Yuzhou Qin, Mingwei Huang, Jiansi Chen, Yang Yang, Jian‐Hong Zhong	19
10	A nomogram to predict vascular invasion before resection of colorectal cancer 2019 ·Oncology Letters ·(unknown), Jungang Liu, Xiaoliang Huang, (unknown), (unknown), (unknown), (unknown), (unknown), Chan Li, Zhengtian Li, Lianying Ge, Weizhong Tang	8
11	Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies 2018 ·PLoS ONE ·Yao Xiong, Qian Zhang, Jiaxiang Ye, Shan-Shan Pan, Lianying Ge	6
12	Fas-associated factor 1 inhibits tumor growth by suppressing Helicobacter pylori-induced activation of NF-κB signaling in human gastric carcinoma 2016 ·Oncotarget ·Aiqun Liu, Zhongqiu Xie, Xiaoni Chen, Jie Feng, Jiawei Chen, Fujun Qin, Lianying Ge	11
13	Identification of pathways related to FAF1/H. pylori-associated gastric carcinogenesis through an integrated approach based on iTRAQ quantification and literature review 2015 ·Journal of Proteomics ·Jiawei Chen, Lianying Ge, A. Q. Liu, (unknown), Jiaxiang Ye, Jian‐Hong Zhong, Li Liu, Xiaoni Chen	12
14	Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer 2015 ·Oncology Reports ·Yuzhou Qin, (unknown), Haizhou Liu, Hao Lai, (unknown), Lianying Ge	32
15	Three ADIPOR1 Polymorphisms and Cancer Risk: A Meta-Analysis of Case-Control Studies 2015 ·PLoS ONE ·Jiaxiang Ye, Li Jiang, Changliang Wu, (unknown), (unknown), Lianying Ge	7
16	Evaluation of miR-29c, miR-124, miR-135a and miR-148a in predicting lymph node metastasis and tumor stage of gastric cancer. 2015 ·PubMed ·Li Liu, Jiaxiang Ye, Yuzhou Qin, (unknown), Lianying Ge	19
17	RNAi-mediated knockdown of the c-jun gene sensitizes radioresistant human nasopharyngeal carcinoma cell line CNE-2R to radiation 2014 ·Oncology Reports ·(unknown), Xiaodong Zhu, Lianying Ge, Song Qu, Ling Li, (unknown), Ya Guo	10
18	Silencing of the hTERT Gene by shRNA Inhibits Colon Cancer SW480 Cell Growth In Vitro and In Vivo 2014 ·PLoS ONE ·Aiqun Liu, Lianying Ge, Xiaoling Lü, Xiaoling Luo, Yanling Cai, (unknown), (unknown)	15
19	Effectiveness and safety profile of S-1-based chemotherapy compared with capecitabine-based chemotherapy for advanced gastric and colorectal cancer: A meta-analysis 2014 ·Experimental and Therapeutic Medicine ·Jiaxiang Ye, Aiqun Liu, Lianying Ge, Shaozhang Zhou, Zhongguo Liang	7
20	HBV A₁₇₆₂T, G₁₇₆₄A Mutations Are a Valuable Biomarker for Identifying a Subset of Male HBsAg Carriers at Extremely High Risk of Hepatocellular Carcinoma: A Prospective Study 2008 ·The American Journal of Gastroenterology ·Zhong‐Liao Fang, Caroline Sabin, Baiqing Dong, Lianying Ge, (unknown), Qin-Yan Chen, (unknown), Jin-ye Yang, Xueyan Wang, Tim J. Harrison	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact